These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36136762)

  • 1. Bioavailability and cardiovascular effects of adrenaline administered by Anapen 500 μg auto-injector in healthy volunteers.
    Duvauchelle T; Robert P; Donazzolo Y; Loyau S; Orlandini B; Lehert P; Lecomte JM; Schwartz JC
    Br J Clin Pharmacol; 2023 Mar; 89(3):1012-1019. PubMed ID: 36136762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability and Cardiovascular Effects of Adrenaline Administered by Anapen Autoinjector in Healthy Volunteers.
    Duvauchelle T; Robert P; Donazzolo Y; Loyau S; Orlandini B; Lehert P; Lecomte JM; Schwartz JC
    J Allergy Clin Immunol Pract; 2018; 6(4):1257-1263. PubMed ID: 29109047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal dose of adrenaline auto-injector for children and young people at risk of anaphylaxis: A phase IV randomized controlled crossover study.
    Patel N; Isaacs E; Duca B; Nagaratnam N; Donovan J; Fontanella S; Turner PJ
    Allergy; 2023 Jul; 78(7):1997-2006. PubMed ID: 36794963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic and pharmacodynamic evidence of adrenaline administered via auto-injector for anaphylactic reactions: A review of literature.
    Moss J; Jani Y; Edwards B; Tomlin S; Rashed AN
    Br J Clin Pharmacol; 2021 Mar; 87(3):816-824. PubMed ID: 32559814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of adrenaline auto-injector devices: ease of use and ability to recall use.
    Robinson MN; Dharmage SC; Tang ML
    Pediatr Allergy Immunol; 2014 Aug; 25(5):462-7. PubMed ID: 25041111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative Bioavailability Study of Midazolam Intramuscularly Administered with the Needle-Free Auto-Injector ZENEO
    Lacombe O; Pletan Y; Grouin JM; Brennan A; Giré O
    Neurol Ther; 2024 May; ():. PubMed ID: 38806873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenaline auto injectors pharmacokinetic/pharmacodynamic studies and potential consequences for clinical practice.
    Worm M; Fox AT; Wickman M; Ring J; Ebisawa M; Pouessel G; Smith P
    Clin Transl Allergy; 2023 Dec; 13(12):e12323. PubMed ID: 38146800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epinephrine delivery via EpiPen
    Worm M; Nguyen D; Rackley R; Muraro A; Du Toit G; Lawrence T; Li H; Brumbaugh K; Wickman M
    Clin Transl Allergy; 2020; 10():21. PubMed ID: 32528643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the robustness and functionality of three adrenaline auto-injectors.
    Schwirtz A; Seeger H
    J Asthma Allergy; 2012; 5():39-49. PubMed ID: 22952410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenaline auto-injectors for the treatment of anaphylaxis with and without cardiovascular collapse in the community.
    Sheikh A; Simons FE; Barbour V; Worth A
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD008935. PubMed ID: 22895980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of practical application steps of the previously used adrenaline auto injector in Turkey (EpiPen) and the currently available adrenaline auto injector (Penepin): a multi-center study.
    Topal E; Karagöl HİE; Yılmaz Ö; Arga M; Köksal B; Yılmaz ÖÖ; Anıl H; Harmancı K; Kutluğ Ş; Öztürk F; Razi HC; Türktaş İ; Demirsoy MS; Bakırtaş A
    Turk Pediatri Ars; 2018 Sep; 53(3):149-154. PubMed ID: 30459513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When should we perform a repeat training on adrenaline auto-injector use for physician trainees?
    Topal E; Bakirtas A; Yilmaz O; Karagol IH; Arga M; Demirsoy MS; Turktas I
    Allergol Immunopathol (Madr); 2014; 42(5):472-5. PubMed ID: 24176470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epinephrine auto-injector needle lengths: Can both subcutaneous and periosteal/intraosseous injection be avoided?
    Dreborg S; Kim L; Tsai G; Kim H
    Ann Allergy Asthma Immunol; 2018 Jun; 120(6):648-653.e1. PubMed ID: 29499370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying the factors and root causes associated with the unintentional usage of an adrenaline auto-injector in Japanese children and their caregivers.
    Sasaki K; Nakagawa T; Sugiura S; Ebisawa M; Ito K
    Allergol Int; 2018 Oct; 67(4):475-480. PubMed ID: 29519764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How far from correct is the use of adrenaline auto-injectors? A survey in Italian patients.
    Ridolo E; Montagni M; Bonzano L; Savi E; Peveri S; Costantino MT; Crivellaro M; Manzotti G; Lombardi C; Caminati M; Incorvaia C; Senna G
    Intern Emerg Med; 2015 Dec; 10(8):937-41. PubMed ID: 25990486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parental knowledge and use of epinephrine auto-injector for children with food allergy.
    Pouessel G; Deschildre A; Castelain C; Sardet A; Sagot-Bevenot S; de Sauve-Boeuf A; Thumerelle C; Santos C
    Pediatr Allergy Immunol; 2006 May; 17(3):221-6. PubMed ID: 16672011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epinephrine auto-injector needle length: what is the ideal length?
    Song TT; Lieberman P
    Curr Opin Allergy Clin Immunol; 2016 Aug; 16(4):361-5. PubMed ID: 27271769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaphylaxis and onsite treatment in schools, kindergartens, and nurseries.
    Korematsu S; Kaku M; Kitada S; Etoh M; Kai H; Joh M; Nakano K; Nakamura M; Sato K; Wakita Y; Matsumoto S; Yada K; Andou A; Ishiwa S; Fujimoto T
    Pediatr Int; 2022 Jan; 64(1):e14973. PubMed ID: 34459057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a Novel Prefilled, Single-Use, Needle-Free Device (Zeneo
    Bardou M; Luu M; Walker P; Auriel C; Castano X
    Adv Ther; 2017 Jan; 34(1):252-260. PubMed ID: 27928757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcutaneous Bioavailability of Taspoglutide at 3 Different Injection Sites in Healthy Overweight/Obese Subjects.
    Sturm-Pellanda C; Abt M; Sanwald-Ducray P; Schmitt C
    Clin Ther; 2015 Nov; 37(11):2439-48. PubMed ID: 26412802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.